|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/18 | |||
| A61K 31/395 | |||
| A61K 31/4985 | |||
| A61K 31/5377 | |||
| A61K 31/4406 | |||
| A61P 35/00 | |||
| A61K 45/06 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Number of the document | 3131550 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15780041.8 |
| Date of filing the European patent application | 2015-04-15 | |
| (97) | Date of publication of the European application | 2017-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/025844 |
| Date | 2015-04-15 |
| (87) | Number | WO 2015/160869 |
| Date | 2015-10-22 |
| (30) | Number | Date | Country code |
| 201461980125 P | 2014-04-16 | US |
| (72) |
TROWE, Torsten Bernhard, US
|
| (73) |
Signal Pharmaceuticals, LLC,
10300 Campus Point Drive Suite 100, San Diego, CA 92121,
US
|
| (54) | METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY WITH A HISTONE DEACETYLASE INHIBITOR |
| METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY WITH A HISTONE DEACETYLASE INHIBITOR |